PubMed COVID-19 Clinical Care
48001 - 48010 of 63288 results found
Ventricular Fibrillation in an Afebrile COVID-19 Patient Presenting With Transient Type-I Brugada Pattern
Description
COVID-19 has been associated with an increased risk of both atrial and ventricular arrhythmias. Brugada syndrome (BrS), an inherited sodium channelopathy presenting with a characteristic ECG morphology, confers a baseline risk of ventricular
Association of Vitamin D levels on the Clinical Outcomes of Patients Hospitalized for COVID-19 in a Tertiary Hospital
Description
CONCLUSION: The inverse relationship between Vitamin D level and poor composite outcome observed in our study suggests that low Vitamin D may be a risk factor for poor prognosis among patients admitted for COVID-19.
Proximity-Induced Nucleic Acid Degrader (PINAD) Approach to Targeted RNA Degradation Using Small Molecules
Description
Nature has evolved intricate machinery to target and degrade RNA, and some of these molecular mechanisms can be adapted for therapeutic use. Small interfering RNAs and RNase H-inducing oligonucleotides have yielded therapeutic agents against diseases
Job Satisfaction and Overcoming the Challenges of Teleworking in Times of COVID-19: A Pilot Study Among Iranian University Community
Description
The coronavirus pandemic changed the academic world in many ways, and most academic institutions continue operating through teleworking. The aim of the present study was to determine how satisfied the university community (faculty/staff members and
Disparities in COVID-19 vaccine hesitancy among a diverse community-based sample in Connecticut, United States
Description
Though vaccination is among our strongest tools to prevent COVID-19 infections, its delivery has proven challenging. At a time when COVID-19 cases were rapidly increasing in the Northeast, we examined the role of sociodemographic factors, social
Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups
Description
CONCLUSION: The generalized immunization schedule for COVID-19 needs to be adjusted for high-risk comorbid groups, and a booster dose must be administered early within 4 months after receiving the second dose.
704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates
Description
Genetic immunization is an attractive approach for prophylactic and therapeutic vaccination using synthetic vectors to deliver antigen-encoding nucleic acids. Recently, DNA delivered by a physical means or RNA by liposomes consisting of four
Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach
Description
This paper investigates the distribution problem of the COVID-19 vaccine at the provincial level in Turkey and the management of medical waste, considering the cold chain requirements and the perishable nature of vaccines. In this context, a novel
A multimodal AI-based non-invasive COVID-19 grading framework powered by deep learning, manta ray, and fuzzy inference system from multimedia vital signs
Description
The COVID-19 pandemic has presented unprecedented challenges to healthcare systems worldwide. One of the key challenges in controlling and managing the pandemic is accurate and rapid diagnosis of COVID-19 cases. Traditional diagnostic methods such as
